» Articles » PMID: 28280088

Radiomics Features of Multiparametric MRI As Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2017 Mar 11
PMID 28280088
Citations 260
Authors
Affiliations
Soon will be listed here.
Abstract

To identify MRI-based radiomics as prognostic factors in patients with advanced nasopharyngeal carcinoma (NPC). One-hundred and eighteen patients (training cohort: = 88; validation cohort: = 30) with advanced NPC were enrolled. A total of 970 radiomics features were extracted from T2-weighted (T2-w) and contrast-enhanced T1-weighted (CET1-w) MRI. Least absolute shrinkage and selection operator (LASSO) regression was applied to select features for progression-free survival (PFS) nomograms. Nomogram discrimination and calibration were evaluated. Associations between radiomics features and clinical data were investigated using heatmaps. The radiomics signatures were significantly associated with PFS. A radiomics signature derived from joint CET1-w and T2-w images showed better prognostic performance than signatures derived from CET1-w or T2-w images alone. One radiomics nomogram combined a radiomics signature from joint CET1-w and T2-w images with the TNM staging system. This nomogram showed a significant improvement over the TNM staging system in terms of evaluating PFS in the training cohort (C-index, 0.761 vs. 0.514; < 2.68 × 10). Another radiomics nomogram integrated the radiomics signature with all clinical data, and thereby outperformed a nomogram based on clinical data alone (C-index, 0.776 vs. 0.649; < 1.60 × 10). Calibration curves showed good agreement. Findings were confirmed in the validation cohort. Heatmaps revealed associations between radiomics features and tumor stages. Multiparametric MRI-based radiomics nomograms provided improved prognostic ability in advanced NPC. These results provide an illustrative example of precision medicine and may affect treatment strategies. .

Citing Articles

Development and evaluation of a deep learning framework for pelvic and sacral tumor segmentation from multi-sequence MRI: a retrospective study.

Yin P, Chen W, Fan Q, Yu R, Liu X, Liu T Cancer Imaging. 2025; 25(1):34.

PMID: 40082955 PMC: 11907785. DOI: 10.1186/s40644-025-00850-8.


Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab.

Jin X, Li W, Guo Y, Wu G, Huang W, Chen F Eur Radiol. 2025; .

PMID: 39953153 DOI: 10.1007/s00330-025-11433-3.


Identification of critical biomarkers and immune landscape patterns in glioma based on multi-database.

Yuan H, Cheng J, Xia J, Yang Z, Xu L Discov Oncol. 2025; 16(1):35.

PMID: 39800804 PMC: 11725551. DOI: 10.1007/s12672-024-01653-2.


Prediction of Persistent Tumor Status in Nasopharyngeal Carcinoma Post-Radiotherapy-Related Treatment: A Machine Learning Approach.

Tseng H, Shen C, Kao P, Chuang C, Yan D, Liao Y Cancers (Basel). 2025; 17(1.

PMID: 39796725 PMC: 11720740. DOI: 10.3390/cancers17010096.


A clinical-radiomics nomogram based on multisequence MRI for predicting the outcome of patients with advanced nasopharyngeal carcinoma receiving chemoradiotherapy.

Chen L, Wang Z, Meng Y, Zhao C, Wang X, Zhang Y Front Oncol. 2024; 14:1460426.

PMID: 39634263 PMC: 11615067. DOI: 10.3389/fonc.2024.1460426.